BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3819516)

  • 1. [Fundamental and clinical study of chemotherapy of refractory choriocarcinoma].
    Kobayashi O; Shirotake S; Matsui H; Sekiya S; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):79-86. PubMed ID: 3819516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of refractory choriocarcinoma].
    Takamizawa Y; Inaba N; Matsui H
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1843-7. PubMed ID: 2393304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study for the experimental chemotherapy and clinical application (author's transl)].
    Katoh T; Ishige H; Kobayashi O; Takamizawa H; Tokita H; Tanaka N
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Feb; 34(2):173-9. PubMed ID: 7061901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental chemotherapy with drug-resistant choriocarcinoma transplanted to nude mice (author's transl)].
    Katoh T; Ishige H; Kobayashi O; Takamizawa H; Tanaka N; Tokita H
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2055-64. PubMed ID: 7200112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of first and second line chemotherapies in gestational choriocarcinoma].
    Matsui H; Eguchi O; Inaba N; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1297-304. PubMed ID: 8258729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic and clinical study of anticancer effect of etoposide on choriocarcinoma].
    Fujii T; Maeda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):593-600. PubMed ID: 3385278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the rationale for chemotherapy of refractory choriocarcinoma].
    Katoh T; Ishige H; Kobayashi O; Takamizawa H
    Gan To Kagaku Ryoho; 1982 May; 9(5):815-21. PubMed ID: 6191704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New combination chemotherapy against drug-resistant choriocarcinoma].
    Matsui H; Kobayashi O; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1087-94. PubMed ID: 3611879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
    Fechtig A; de Dycker RP; Schumacher T; Zajaczkowski T; Neumann RL
    Geburtshilfe Frauenheilkd; 1992 Apr; 52(4):235-8. PubMed ID: 1607119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presentation and management of post-partum choriocarcinoma.
    Dobson LS; Gillespie AM; Coleman RE; Hancock BW
    Br J Cancer; 1999 Mar; 79(9-10):1531-3. PubMed ID: 10188902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
    Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
    Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of cytotoxicity in cultured choriocarcinoma cell lines using methotrexate and actinomycin-D].
    Hayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1641-8. PubMed ID: 6684671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study of drug sensitivity on newly established three choriocarcinoma cell lines].
    Okayama Y; Goto S; Fan C; Ueda S; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):17-23. PubMed ID: 3819510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic choriocarcinoma presenting and treated during viable pregnancy: a case report.
    Bircher C; Smith RP; Seckl MJ; Brown D; Short D; Rees H; McCarthy A; Nirmal DM
    BJOG; 2011 Dec; 118(13):1672-5. PubMed ID: 21790953
    [No Abstract]   [Full Text] [Related]  

  • 15. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk choriocarcinoma.
    Bagshawe KD
    J Reprod Med; 1984 Nov; 29(11):813-20. PubMed ID: 6097685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methotrexate in gynecologic oncology].
    Isonishi S; Terashima Y
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective arterial catheterization in the management of drug-resistant choriocarcinoma].
    Yang X; Yang N; Song H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):199-202. PubMed ID: 8758771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational choriocarcinoma: morphological features in a liquid-based endometrial cytological sample.
    Garbini F; Buccoliero AM; Castiglione F; Gheri CF; Moncini D; Rossi Degl'Innocenti D; Barbetti A; Villanucci A; Taddei GL
    Diagn Cytopathol; 2008 Feb; 36(2):113-4. PubMed ID: 18181184
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of cis-platinum (CDDP) on methotrexate-resistant choriocarcinoma cell line].
    Sagawa T; Yamashita K; Kawamura M; Shimizu T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):203-9. PubMed ID: 3958517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.